Aug 1 |
Precision BioSciences GAAP EPS of $4.70 beats by $6.32, revenue of $49.9M beats by $41.58M
|
Aug 1 |
Precision BioSciences: Q2 Earnings Snapshot
|
Aug 1 |
Precision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update
|
Jul 31 |
Precision BioSciences Q2 2024 Earnings Preview
|
Jul 31 |
Precision BioSciences to Participate in Upcoming August Investor Conferences
|
Jul 29 |
Precision BioSciences to Report Second Quarter Results on August 1, 2024
|
Jul 8 |
Precision BioSciences to Present at the Upcoming JonesTrading Healthcare Seaside Summit
|
Jul 1 |
Precision BioSciences joins Russell Microcap Index
|
Jul 1 |
Precision BioSciences Announces its Addition to the Russell Microcap® Index
|
Jun 27 |
Precision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025
|